Liposome Drug Delivery Market PPT
                     Liposome Drug Delivery Market  
Liposome Drug Delivery Market Forecast to 
2027 - COVID-19 Impact and Global 
Analysis by Product (Liposomal 
Doxorubicin, Liposomal Paclitaxel, 
Liposomal Amphotericin B, Others); 
Technology ( Stealth Liposome Technology, 
Non-PEGylated Liposome Technology, 
DepoFoam Liposome Technology, Lysolipid 
Thermally Sensitive Liposome (LTSL)); 
Application (Fungal Diseases, Cancer 
Therapy, Pain Management, Viral Vaccines, 
Photodynamic Therapy)
Liposome Drug Delivery Market 
Current and future Market Scenario
 According to the new market research study of "Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact 
and Global Analysis by Product, Technology, Application, and Geography  the market is expected to reach US$ 6,992.95 
million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow with a CAGR of 8.8% from 2020 to 
2027.
 The market is estimated to grow with a CAGR of 8.8 % from 2020-2027. The report highlights trends prevailing in the 
global liposome drug delivery market and the factors driving market along with those that act as hindrances. 
 The liposome drug delivery market, by application, is segmented into fungal diseases, cancer therapy, pain 
management, viral vaccines, and photodynamic therapy. In 2019, the cancer therapy segment accounted for the largest 
market share of the global liposome drug delivery market. 
 This segment is also expected to dominate the market in 2027. The large share of cancer therapy  factor concentrates 
liposome-based treatments have gained popularity to overcome the problems and side effects of the conventional 
chemotherapy treatment. 
Key Findings
 On the other hand,  drug delivery systems enhance the therapeutic index of anticancer agents and these biomolecules 
have a natural ability to target cancer cells. The aforementioned factors are likely to be responsible for the growth of 
the segment in the liposome drug delivery market.
 Over the past few decades, R&D activities in liposomal drug delivery systems have rapidly increased across the world 
due to increasing prevalence of chronic disease.  Liposomal drugs have high encapsulation capacity and hence show a 
significant anticancer activity with decreased toxicity.
Market Insights
Increasing Prevalence of Chronic Diseases 
Drug delivery is the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. 
 Drug delivery is the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. 
Liposomal drug delivery offers various advantages, such as improved pharmacokinetics and pharmacodynamics, enhanced 
therapeutic efficacy, and decreased toxicity, thereby making these delivery systems ideal for patients suffering from 
various chronic conditions. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 
people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases. 
Liposome Drug Delivery Market  
Market Segments
Technology ( Stealth Liposome 
Technology, Non-PEGylated  Application (Fungal Diseases, 
By Product (Liposomal Liposome Technology, Cancer Therapy, Pain 
Doxorubicin, Liposomal DepoFoam Liposome Management, Viral Vaccines, 
Paclitaxel, Liposomal Technology, Lysolipid Photodynamic Therapy)
Amphotericin B, Others) Thermally Sensitive Liposome )
(LTSL))
Liposome Drug Delivery Market  
 
Dominating Segments
 
 Liposomes, a novel drug delivery system (NDDS), are bilayer vesicular structures used in delivering drugs or 
genetic material into a cell. The aim of NDDS is to deliver the drug at a rate directed by the needs of the body 
  during the period of treatment.
 Targeted drug delivery system (TDDS) delivers the drug in a controlled manner at a preselected biosite. 
Nanotechnology-based delivery systems are making a significant impact on cancer treatment and the 
polymers play a key role in the development of nanoparticulate carriers for cancer therapy.
 Cancer is one of the leading causes of death among population worldwide. The American Cancer Society 
(ACS) estimated that ~1,735,350 new cancer cases were diagnosed in 2018. For instance, in April 2019, Ipsen 
Pharma completed its acquisition of global oncology assets from Merrimack Pharmaceuticals, Cambridge that 
focuses on ONIVYDE (irinotecan liposome injection) for the treatment of patients with metastatic 
adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. 
Dominating Segments
Product Insights
Products Insights
 The liposome drug delivery market, based on product, is segmented into liposomal doxorubicin, liposomal 
paclitaxel, liposomal amphotericin B, and others. In 2019, the liposomal doxorubicin accounted for the largest 
share by product owing to the high efficacy of the drug exhibited in the treatment of cancer.
 the liposomal doxorubicin is beneficial over its traditional counterpart in terms of toxicity and targeted drug 
delivery. The drug also exhibits significant recovery among patients suffering with HIV-related Kaposi’s sarcoma 
and multiple myeloma.
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPRE00010407/?source=others-10389 
Dominating Segments
The report analyzes liposome drug delivery market on the basis of following segments:
By Product
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
By Technology
Stealth Liposome Technology
Non-PEGylated Liposome Technology
DepoFoam Liposome Technology
Lysolipid Thermally Sensitive Liposome (LTSL) Technology
Dominating Segments
By Application
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
Liposome Drug Delivery Market  
Leading Players
Company Profiles in Liposome Drug Delivery Market are:
Takeda Pharmaceutical Company Limited
Novartis AG
Luye Pharma Group
Ipsen Pharma
CELSION, Inc.
Gilead Sciences, Inc.
Astellas Pharma, Inc.
Johnson & Johnson Services, Inc.
Acrotech Biopharma, Inc.
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Liposome Drug Delivery Market  
 
 Liposome Drug Delivery Market  
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/liposome-drug-delivery-market?source=others-10389 
Thank You! 
Thank You!